faCellitate GmbH, a pioneering company in advanced cell culture technologies, has proudly secured 1st place in the prestigious Technology Category at the 2024 Mannheim Business Start-Up Award (MEXI), sponsored by Roche Diagnostics. This accolade, awarded during the 20th anniversary of MEXI, recognizes faCellitate's cutting-edge innovation, BIOFLOAT™, a revolutionary coating for 3D cell cultures transforming the landscape of drug development and regenerative medicine.
MEXI, one of Germany’s most highly endowed start-up awards, celebrated its 20th year with a grand event at the Musikpark in Mannheim. The ceremony, organized by the Mannheim Economic Development Agency in partnership with NEXT MANNHEIM, honoured twelve visionary finalists across four categories: Technology, Services, Social Economy, and Fashion. faCellitate GmbH emerged as the top winner in the Technology category, impressing the jury with its ground-breaking technology to reduce the need for animal models in drug testing, offering innovative options for regenerative medicine and biotechnology.
“It is an incredible honour to be recognized at MEXI, especially in its anniversary year,” said Dr. Simon Widmaier, CEO of faCellitate GmbH. “Our team has been dedicated to advancing innovative solutions for 3D cell culture. Winning this award validates our hard work and inspires us to continue to advance cutting edge solutions in biomedicine.”
As recently published in a peer-reviewed journal BIOFLOAT™ by faCellitate is one of the world’s most advanced coatings for 3D cell cultures. The technology is designed to accelerate drug development by offering more predictive human-based models, reducing the dependency on animal testing, and opening new doors for applications in personalised medicine, cancer research, and beyond.
MEXI, one of Germany’s most highly endowed start-up awards, celebrated its 20th year with a grand event at the Musikpark in Mannheim. The ceremony, organized by the Mannheim Economic Development Agency in partnership with NEXT MANNHEIM, honoured twelve visionary finalists across four categories: Technology, Services, Social Economy, and Fashion. faCellitate GmbH emerged as the top winner in the Technology category, impressing the jury with its ground-breaking technology to reduce the need for animal models in drug testing, offering innovative options for regenerative medicine and biotechnology.
“It is an incredible honour to be recognized at MEXI, especially in its anniversary year,” said Dr. Simon Widmaier, CEO of faCellitate GmbH. “Our team has been dedicated to advancing innovative solutions for 3D cell culture. Winning this award validates our hard work and inspires us to continue to advance cutting edge solutions in biomedicine.”
As recently published in a peer-reviewed journal BIOFLOAT™ by faCellitate is one of the world’s most advanced coatings for 3D cell cultures. The technology is designed to accelerate drug development by offering more predictive human-based models, reducing the dependency on animal testing, and opening new doors for applications in personalised medicine, cancer research, and beyond.
